Updates

Event
|

E-Panel and live Q&A: "Accelerate to Equal: Engaging Women in Vector Control"

Register to watch the panel discussion "Accelerate to Equal: Engaging Women in Vector Control" on October 1st, 2019. Panellists will discuss various aspects of women as important actors in vector-control initiatives. You will be able to put your own questions to the panellists of this Virtual Keystone Symposia through the live Q&A.
Event
|

Lecture: Magic Bullets & Malaria

LSHTM Malaria Centre will host an inaugural lecture about “magic bullets” to fight Malaria by Professor Umberto D’Alessandro, who has long working experience in Africa, first as a clinician and later as a clinical epidemiologist. The lecture will be on Wednesday 11 September 2019. 
Event
|

The Malaria Endgame: Innovation in Therapeutics, Vector Control and Public Health Tools

"The Malaria Endgame: Innovation in Therapeutics, Vector Control and Public Health Tools" Conference, part of the Keystone Symposia Global Health Series, will take place in Addis Ababa, Ethiopia on October 30 - November 2, 2019.
Event
|

MESA Correspondents reporting from the 7th International Conference on Plasmodium vivax research

The MESA Correspondents Program will cover the science and discussions from the 7th International Conference on Plasmodium vivax Research (ICPvR), which will take place in Paris on June 26th-28th, 2019. Summaries will be posted online at www.vivax2019.conferences-pasteur.org and www.mesamalaria.org/resource-hub/correspondents.
Event
|

Webinar: The Global Fund, Governance and Public Health

The Consortium of Universities for Global Health is hosting a webinar on Thursday, June 27th, at 1 pm to discuss what happens, and what needs to happen on the crossroads of governance and public health.
Event
|

Webinaire: Identifier les Défis et les Opportunités des Systèmes de Distribution Continue de LLIN

The President’s Malaria Initiative VectorLink Project is hosting a webinar in French, Monday June 3rd, at 9am EST. The partners from PSI will be discussing results from a recent ITN continuous distribution assessment conducted in Cameroon, Niger, and Burkina Faso. It is expected to have members from NCMP from each country presenting as well.
Event
|

Virtual Keystone Symposium 'Drug Discovery in Africa', June 5, 2019

A panel of experts will discuss opportunities and challenges in drug discovery research in African countries. The discussion will be broadcast on June 5th 2019 followed by live Q&A with the panellists. Questions can be submitted during the broadcast via Twitter or the chat room, or in advance when registering for the event.

The panel is organised by Keystone Symposia.

Registration is free.

Read more here.


 

Event
|

5th International Conference on Malaria Vaccines for the World (MVW 2019)

The 5th International conference on Malaria Vaccines for the World (MVW) was held on May 8-10 at the University of Oxford, UK. The current status of new technologies, vaccine candidates, clinical trials and the RTS,S implementation studies were discussed during three intensive days, and here you can read coverage of each session from the MESA Correspondents.  
Event
|

Panel Discussion: Eliminating Malaria: evidence, impact, and policy

LSHTM Malaria Centre, together with the Malaria Consortium and the Wellcome Trust, will host an evening panel discussion as part of this year’s ongoing World Malaria Day campaign on Tuesday 30 April 2019.
Event
|

Virtual Keystone Symposium: "Mosquito-Borne Diseases: From Long-Time Foes to Emerging Threats"

Join this free e-panel on mosquito-borne diseases featuring live Q&A with the panellists and additional expert guests on February 27th, 2019.
Event
|

MESA co-hosting a critical global gathering in response to the latest disease reality and future innovation and financing needs

The MESA Alliance is set to co-host an invite-only scientific symposium entitled, “Innovate for Collective Impact to End Malaria,” on Friday, January 11, 2019, at the National Academy of Sciences in Washington, DC, USA. Its core objective is to frame a response to the 2018 World Malaria Report and to develop innovative approaches to collectively bridge critical issues in malaria eradication spanning research, financing, and implementation.
Event
|

ASTMH presentations now online

In collaboration with ASTMH, Image Audiovisuals, and session presenters, MESA brings you nearly 70 presentations from the 65th ASTMH annual meeting in Atlanta, November 2016.
Event
|

SAVE THE DATE: Keystone Symposia Conference, Uganda, 19-23 February 2017

MESA has teamed up with Keystone Symposia once again to offer scientists an arena where they can network, think creatively and exchange ideas to meet the challenge of eradicating malaria.

Event
|

Malaria Elimination Sessions at ASTMH

The 64th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) is taking place 25 – 29 October 2015 in Philadelphia, USA.

Partners from across the malaria community will be sharing updates of their work.

Event
|

ECTMIH 2015: special focus on malaria control & elimination from innovation to application

Malaria will feature as a key topic in the ECTMIH congress in Basel September 6-10. Topics will include: 
 

  • insecticide resistance
  • drug resistance
  • the importance of P.vivax
  • implementation science
  • drug delivery
  • vaccines

as well as cross-cutting sessions on malaria transmission and malaria elimination. 

Researchers are encouraged to submit there abstracts on line throug the ECTMIH website before Thursday, 9 April 2015. 

Event
|

9th European Congress on Tropical Medicine and International Health

"Driving the Best Science to Meet Global Health Challenges" The 9th European Congress on Tropical Medicine and International Health in Basel, 6 - 10 September 2015. Registration and Call for Abstracts are now open. Submit your abstract until the 9th April 2015. 
Event
|

Keystone Symposia Meeting on The Science of Malaria Eradication

Date: Sunday, 2 February 2014 - Friday, 7 February 2014 Location: Mérida (Yucatán) México Scientific Organizers: Pedro L. Alonso, Chetan E. Chitnis and Lee Hall Organized in collaboration with MESA – Malaria Eradication Scientific Alliance
Event
|

Webinar 'Evaluating antimalarial safety' from ACT consortium, Oct 7th 2014

Clinical trials are not suitable to identify rare, potentially serious adverse effects of drugs, or to define their safety in high risk populations.

Artemisinin-based combination therapies (or ACTs) are considered safe, but there are concerns over their potential to cause damage to parts of the brain. There is also a concern about their safety in patients infected with HIV.

Collating safety data is a challenge in Africa, where most antimalarials are used and more vulnerable populations reside.